{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:42:27Z","timestamp":1793817747717,"version":"4.6.1"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is a biologically heterogeneous malignancy of the male genitourinary tract. Once the disease progresses to advanced stages, particularly castration-resistant PCa (CRPC), available treatment options become significantly limited. Although immunotherapy has demonstrated substantial clinical success in various solid tumors, its clinical benefit in PCa has been largely disappointing, mainly due to the profoundly immunosuppressive tumor microenvironment (TME).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Tumor-associated macrophages (TAMs) represent a dominant immune cell population within the PCa immune microenvironment, and their functional states are closely linked to tumor progression and therapeutic responsiveness. Emerging evidence indicates that TAMs actively communicate with tumor cells and other immune subsets through the secretion of extracellular vesicles (EVs). These vesicles serve as important mediators of intercellular signaling, contributing to immune suppression, tumor progression, and the development of resistance to therapy. In this review, we comprehensively summarize recent advances in understanding the biological roles of macrophage-derived EVs (M\u03c6-EVs) in PCa, with particular emphasis on their involvement in immune microenvironment remodeling, tumor-promoting activities, and therapeutic resistance mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>M\u03c6-EVs have emerged as key regulators of immunosuppression and treatment failure in PCa. A deeper understanding of their functional networks may provide novel opportunities for the development of EV-based diagnostic biomarkers and therapeutic strategies, ultimately helping to optimize immunotherapy and improve clinical outcomes in PCa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08074-5","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:57:19Z","timestamp":1775296639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Macrophage-derived extracellular vesicles in the remodeling of the prostate cancer immune microenvironment and therapeutic resistance"],"prefix":"10.1186","volume":"24","author":[{"given":"Zixiong","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"issue":"1","key":"8074_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-022-03846-1","volume":"21","author":"M Bauckneht","year":"2023","unstructured":"Bauckneht M, Marini C, Cossu V, et al. Gene\u2019s expression underpinning the divergent predictive value of [18F] F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study. J Educ Chang Transl Med. 2023\/3\/4;21(1):3. https:\/\/doi.org\/10.1186\/s12967-022-03846-1.","journal-title":"J Educ Chang Transl Med"},{"issue":"2","key":"8074_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.17305\/bb.2023.9753","volume":"24","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Fu Z-Y, Feng H-Y, et al. Parathyroid hormone-related protein as a potential prostate cancer biomarker: promoting prostate cancer progression through upregulation of c-met expression. Biomol Biomed. 2024\/3\/11;24(2):374\u201386. https:\/\/doi.org\/10.17305\/bb.2023.9753.","journal-title":"Biomol Biomed"},{"key":"8074_CR3","doi-asserted-by":"publisher","unstructured":"Zhao Z, Hu Y, Li H, et al. Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts. J Immunother Cancer. 2025\/3\/22;13(3):e010555. https:\/\/doi.org\/10.1136\/jitc-2024-010555.","DOI":"10.1136\/jitc-2024-010555"},{"issue":"17","key":"8074_CR4","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.3390\/cancers13174387","volume":"13","author":"M Borgia","year":"2021","unstructured":"Borgia M, Dal Bo M, Toffoli G. Role of virus-related chronic inflammation and mechanisms of cancer immune-suppression in pathogenesis and progression of hepatocellular carcinoma. Cancers. 2021\/8\/30;13(17):4387. https:\/\/doi.org\/10.3390\/cancers13174387.","journal-title":"Cancers"},{"key":"8074_CR5","doi-asserted-by":"publisher","unstructured":"Shi T, Zhou S, Zhang T, et al. Establishment of a monoclonal antibody-based enzyme-linked immunosorbent assay to measure soluble B7-H5 in patients with cancer. J Immunol Res. 2022;1\u20138. https:\/\/doi.org\/10.1155\/2022\/3013185.","DOI":"10.1155\/2022\/3013185"},{"issue":"1","key":"8074_CR6","doi-asserted-by":"publisher","first-page":"20220559","DOI":"10.1515\/biol-2022-0559","volume":"18","author":"Z Su","year":"2023","unstructured":"Su Z, Zhang L, Xue S, Wang Y, Ding R. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: a systematic review and meta-analysis. Open Life Sci. 2023\/3\/1;18(1):20220559. https:\/\/doi.org\/10.1515\/biol-2022-0559.","journal-title":"Open Life Sci"},{"issue":"5","key":"8074_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1158\/2326-6066.CIR-24-0591","volume":"13","author":"AN Clements","year":"2025","unstructured":"Clements AN, Casillas AL, Flores CE, et al. Inhibition of PIM kinase in tumor-associated macrophages suppresses Inflammasome activation and sensitizes prostate cancer to immunotherapy. Cancer Immunol Res. 2025\/5\/2;13(5):633\u201345. https:\/\/doi.org\/10.1158\/2326-6066.CIR-24-0591.","journal-title":"Cancer Immunol Res"},{"key":"8074_CR8","doi-asserted-by":"publisher","unstructured":"Chen S, Lu K, Hou Y, et al. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. J Immunother Cancer. 2023\/4;11(4):e006020. https:\/\/doi.org\/10.1136\/jitc-2022-006020.","DOI":"10.1136\/jitc-2022-006020"},{"key":"8074_CR9","doi-asserted-by":"publisher","unstructured":"Che J, Liu Y, Liu Y, et al. The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise. Front Immunol. 2025\/3\/12\/, 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1544882.","DOI":"10.3389\/fimmu.2025.1544882"},{"issue":"1","key":"8074_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13073-025-01445-5","volume":"17","author":"DJ Vis","year":"2025","unstructured":"Vis DJ, Palit SAL, Corradi M, et al. Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications. Genome Med. 2025\/3\/20;17(1):24. https:\/\/doi.org\/10.1186\/s13073-025-01445-5.","journal-title":"Genome Med"},{"issue":"6","key":"8074_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1159\/000541881","volume":"103","author":"R Novysedlak","year":"2024","unstructured":"Novysedlak R, Guney M, Al Khouri M, et al. The immune microenvironment in prostate cancer: a comprehensive review. Oncology. 2024\/10\/9;103(6):521\u201345. https:\/\/doi.org\/10.1159\/000541881.","journal-title":"Oncology"},{"issue":"2","key":"8074_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41391-024-00825-z","volume":"28","author":"B Fang","year":"2024","unstructured":"Fang B, Lu Y, Li X, et al. Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer. Prostate Cancer Prostatic Dis. 2024\/4\/2;28(2):260\u201369. https:\/\/doi.org\/10.1038\/s41391-024-00825-z.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"8074_CR13","doi-asserted-by":"publisher","unstructured":"Li N, Liu Q, Han Y, et al. ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression. Nat Commun. 2022\/11\/26;13(1). https:\/\/doi.org\/10.1038\/s41467-022-34871-9.","DOI":"10.1038\/s41467-022-34871-9"},{"issue":"4","key":"8074_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/jcm2040264","volume":"2","author":"B Demirkan","year":"2013","unstructured":"Demirkan B. The roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in breast cancer bone metastasis: potential targets for prevention and treatment. JCM. 2013\/11\/22;2(4):264\u201382. https:\/\/doi.org\/10.3390\/jcm2040264.","journal-title":"JCM"},{"key":"8074_CR15","doi-asserted-by":"publisher","first-page":"996805","DOI":"10.3389\/fcell.2022.996805","volume":"10","author":"JJW Low","year":"2022","unstructured":"Low JJW, Sulaiman SA, Johdi NA, Abu N. Immunomodulatory effects of extracellular vesicles in glioblastoma. Front Cell Dev Biol. 2022\/11\/16;10:996805. https:\/\/doi.org\/10.3389\/fcell.2022.996805.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"8074_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.canlet.2015.12.022","volume":"380","author":"SL Shiao","year":"2016","unstructured":"Shiao SL, Chu G-Y, Chung LWK. Regulation of prostate cancer progression by the tumor microenvironment. Cancer Lett. 2016\/9\/28;380(1):340\u201348. https:\/\/doi.org\/10.1016\/j.canlet.2015.12.022.","journal-title":"Cancer Lett"},{"key":"8074_CR17","doi-asserted-by":"publisher","unstructured":"Boccacino JM, Santos Peixoto R, CFdL F, et al. Integrated transcriptomics uncovers an enhanced association between th e prion protein gene expression and vesicle dynamics signatures in glioblastomas. BMC Cancer. 2024\/2\/13;24(1). https:\/\/doi.org\/10.1186\/s12885-024-11914-6.","DOI":"10.1186\/s12885-024-11914-6"},{"issue":"1","key":"8074_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12964-023-01232-y","volume":"21","author":"HEG Ghaleh","year":"2023","unstructured":"Ghaleh HEG, Vakilzadeh G, Zahiri A, Farzanehpour M. Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery. Cell Commun Signal. 2023\/9\/4;21(1):228. https:\/\/doi.org\/10.1186\/s12964-023-01232-y.","journal-title":"Cell Commun Signal"},{"key":"8074_CR19","doi-asserted-by":"publisher","unstructured":"Han T, Hao Q, Chao T, et al. Extracellular vesicles in cancer: golden goose or Trojan horse. J Mol Cell Biol. 2024\/10\/21;16(5):mjae025. https:\/\/doi.org\/10.1093\/jmcb\/mjae025.","DOI":"10.1093\/jmcb\/mjae025"},{"key":"8074_CR20","doi-asserted-by":"publisher","first-page":"1051998","DOI":"10.3389\/fimmu.2022.1051998","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Li S, Li C, Li T, Huang Y. Remodeling tumor microenvironment with natural products to overcome drug resistance. Front Immunol. 2022\/11\/10;13:1051998. https:\/\/doi.org\/10.3389\/fimmu.2022.1051998.","journal-title":"Front Immunol"},{"key":"8074_CR21","doi-asserted-by":"publisher","first-page":"1548724","DOI":"10.3389\/fcell.2025.1548724","volume":"13","author":"MC Rodriguez-Baili","year":"2025","unstructured":"Rodriguez-Baili MC, Palma-Cobo M, Prucca CG, Y\u00e1\u00f1ez-M\u00f3 M, Gil GA. Intercellular communication between extracellular vesicles from conditioned macrophages and breast cancer cells drives endocrine therapy resistance. Front. Cell Dev. Biol. 2025\/6\/3;13:1548724. https:\/\/doi.org\/10.3389\/fcell.2025.1548724.","journal-title":"Front. Cell Dev. Biol"},{"issue":"6","key":"8074_CR22","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/biomedicines13061356","volume":"13","author":"K Kie\u0142bowski","year":"2025","unstructured":"Kie\u0142bowski K, Plewa P, Szulc J, \u0106mil M, Bakinowska E, Pawlik A. Extracellular vesicles and PD-L1-A review of complex Immunoregulatory properties and clinical Importance. Biomedicines. 2025\/5\/31;13(6):1356. https:\/\/doi.org\/10.3390\/biomedicines13061356.","journal-title":"Biomedicines"},{"key":"8074_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fimmu.2020.00013","volume":"11","author":"M Xie","year":"2020","unstructured":"Xie M, Xiong W, She Z, et al. Immunoregulatory effects of stem cell-derived extracellular vesicles on immune cells. Front Immunol. 2020\/2\/11;11:13. https:\/\/doi.org\/10.3389\/fimmu.2020.00013.","journal-title":"Front Immunol"},{"issue":"17","key":"8074_CR24","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3390\/cells13171428","volume":"13","author":"W Zhou","year":"2024","unstructured":"Zhou W, Yang F, Zhang X. Roles of M1 macrophages and their extracellular vesicles in cancer therapy. Cells. 2024\/8\/26;13(17):1428. https:\/\/doi.org\/10.3390\/cells13171428.","journal-title":"Cells"},{"issue":"1","key":"8074_CR25","doi-asserted-by":"publisher","first-page":"114855","DOI":"10.1016\/j.yexcr.2025.114855","volume":"455","author":"CS Amorim","year":"2026","unstructured":"Amorim CS, Moraes JA, Renovato-Martins M, Motta JM. Extracellular vesicles from tumor-associated macrophages: implications for tumor progression and emerging therapeutic strategies. Exp Cell Res. 2026\/2\/1;455(1):114855. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114855.","journal-title":"Exp Cell Res"},{"issue":"7","key":"8074_CR26","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/biomedicines10071493","volume":"10","author":"C Moreno","year":"2022","unstructured":"Moreno C, Haynie C, Cheever A, Weber K. Alternative CAR therapies: recent approaches in engineering chimeric antigen receptor immune cells to combat cancer. Biomedicines. 2022\/6\/24;10(7):1493. https:\/\/doi.org\/10.3390\/biomedicines10071493.","journal-title":"Biomedicines"},{"issue":"4","key":"8074_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00467-017-3883-1","volume":"34","author":"HI Han","year":"2019","unstructured":"Han HI, Skvarca LB, Espiritu EB, Davidson AJ, Hukriede NA. The role of macrophages during acute kidney injury: destruction and repair. Pediatr Nephrol. 2019\/4;34(4):561\u201369. https:\/\/doi.org\/10.1007\/s00467-017-3883-1.","journal-title":"Pediatr Nephrol"},{"issue":"19","key":"8074_CR28","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1002\/1873-3468.12771","volume":"591","author":"K Rabold","year":"2017","unstructured":"Rabold K, Netea MG, Adema GJ, Netea-Maier RT. Cellular metabolism of tumor-associated macrophages - functional impact and consequences. FEBS Lett. 2017\/8\/11;591(19):3022\u201341. https:\/\/doi.org\/10.1002\/1873-3468.12771.","journal-title":"FEBS Lett"},{"issue":"2","key":"8074_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3892\/ijo.2023.5599","volume":"64","author":"C Lu","year":"2024","unstructured":"Lu C, Liu Y, Miao L, et al. Research progress on the role of tumor\u2011associated macrophages in tumor development and their use as molecular targets (review). Int J Oncol. 2024\/2\/\/x;64(2):11. https:\/\/doi.org\/10.3892\/ijo.2023.5599.","journal-title":"Int J Oncol"},{"key":"8074_CR30","doi-asserted-by":"publisher","first-page":"925266","DOI":"10.3389\/fimmu.2022.925266","volume":"13","author":"Z Yi","year":"2022","unstructured":"Yi Z, Ma T, Liu J, et al. The yin-yang effects of immunity: from monoclonal gammopathy of undetermined significance to multiple myeloma. Front Immunol. 2022\/7\/25;13:925266. https:\/\/doi.org\/10.3389\/fimmu.2022.925266.","journal-title":"Front Immunol"},{"issue":"1","key":"8074_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12672-025-01747-5","volume":"16","author":"M Zhang","year":"2025","unstructured":"Zhang M, Huang K, Yin Q, Wu X, Zhu M, Li M. Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy. Discover Oncol. 2025\/1\/7;16(1):15. https:\/\/doi.org\/10.1007\/s12672-025-01747-5.","journal-title":"Discover Oncol"},{"key":"8074_CR32","doi-asserted-by":"publisher","first-page":"1199631","DOI":"10.3389\/fimmu.2023.1199631","volume":"14","author":"S Xu","year":"2023","unstructured":"Xu S, Wang C, Yang L, et al. Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy. Front Immunol. 2023\/5\/29;14:1199631. https:\/\/doi.org\/10.3389\/fimmu.2023.1199631.","journal-title":"Front Immunol"},{"key":"8074_CR33","doi-asserted-by":"publisher","first-page":"1476565","DOI":"10.3389\/fimmu.2024.1476565","volume":"15","author":"J Cao","year":"2024","unstructured":"Cao J, Liu C. Mechanistic studies of tumor-associated macrophage immunotherapy. Front Immunol. 2024\/9\/30;15:1476565. https:\/\/doi.org\/10.3389\/fimmu.2024.1476565.","journal-title":"Front Immunol"},{"key":"8074_CR34","doi-asserted-by":"publisher","unstructured":"Campbell MJ, Wolf D, Mukhtar RA, et al. The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context. PLoS One. 2013;8(10):e79114. https:\/\/doi.org\/10.1371\/journal.pone.0079114.","DOI":"10.1371\/journal.pone.0079114"},{"key":"8074_CR35","doi-asserted-by":"publisher","first-page":"698068","DOI":"10.3389\/fcell.2021.698068","volume":"9","author":"A Zhou","year":"2021","unstructured":"Zhou A, Wu B, Yu H, et al. Current understanding of osteoimmunology in certain osteoimmune Diseases. Front. Cell Dev. Biol. 2021\/8\/17;9:698068. https:\/\/doi.org\/10.3389\/fcell.2021.698068.","journal-title":"Front. Cell Dev. Biol"},{"issue":"9","key":"8074_CR36","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/brainsci13091269","volume":"13","author":"J Ren","year":"2023","unstructured":"Ren J, Xu B, Ren J, et al. The Importance of M1-and M2-polarized macrophages in glioma and as potential treatment targets. Brain Sci. 2023\/8\/31;13(9):1269. https:\/\/doi.org\/10.3390\/brainsci13091269.","journal-title":"Brain Sci"},{"key":"8074_CR37","doi-asserted-by":"publisher","first-page":"638763","DOI":"10.3389\/fimmu.2021.638763","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Wang Y, Li X, Feng G, Hu S, Bai Y. The Impact of NOTCH pathway alteration on tumor microenvironment and clinical survival of immune checkpoint inhibitors in NSCLC. Front Immunol. 2021\/7\/9;12:638763. https:\/\/doi.org\/10.3389\/fimmu.2021.638763.","journal-title":"Front Immunol"},{"key":"8074_CR38","doi-asserted-by":"publisher","unstructured":"Truxova I, Cibula D, Spisek R, Fucikova J. Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma. J Immunother Cancer. 2023\/2;11(2):e005968. https:\/\/doi.org\/10.1136\/jitc-2022-005968.","DOI":"10.1136\/jitc-2022-005968"},{"key":"8074_CR39","doi-asserted-by":"publisher","unstructured":"Wang Y, Liu N, Guo X, et al. The immune microenvironment in endometrial carcinoma: mechanisms and therapeutic targeting. Front Immunol. 2025 Jul 17;16. https:\/\/doi.org\/10.3389\/fimmu.2025.1586315.","DOI":"10.3389\/fimmu.2025.1586315"},{"key":"8074_CR40","doi-asserted-by":"publisher","unstructured":"Jin X, Zhang N, Yan T, et al. Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential. Front Immunol. 2025\/5\/13\/, 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1573039.","DOI":"10.3389\/fimmu.2025.1573039"},{"key":"8074_CR41","doi-asserted-by":"publisher","unstructured":"Soboh S, Vorontsova A, Farhoud M, et al. Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization. Cell Death Disease. 2024\/12\/18;15(12). https:\/\/doi.org\/10.1038\/s41419-024-07262-9.","DOI":"10.1038\/s41419-024-07262-9"},{"issue":"1","key":"8074_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3892\/or.2024.8847","volume":"53","author":"H Yun","year":"2025","unstructured":"Yun H, Dong F, Wei X, et al. Role and value of the tumor microenvironment in the progression and treatment resistance of gastric cancer (review). Oncol Rep. 2025\/1;53(1):14. https:\/\/doi.org\/10.3892\/or.2024.8847.","journal-title":"Oncol Rep"},{"key":"8074_CR43","doi-asserted-by":"publisher","unstructured":"Strachan DC, Ruffell B, Oei Y, et al. CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells. Oncoimmunology. 2013\/12\/1;2(12):e26968. https:\/\/doi.org\/10.4161\/onci.26968.","DOI":"10.4161\/onci.26968"},{"issue":"1","key":"8074_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014\/7\/17;41(1):49\u201361. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.010.","journal-title":"Immunity"},{"key":"8074_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8580043","volume":"2022","author":"C Han","year":"2022","unstructured":"Han C, Deng Y, Xu W, et al. The roles of tumor-associated macrophages in prostate cancer. J Oncol. 2022\/9\/7;2022:1\u201320. https:\/\/doi.org\/10.1155\/2022\/8580043.","journal-title":"J Oncol"},{"issue":"2","key":"8074_CR46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/life13020333","volume":"13","author":"JK Messex","year":"2023","unstructured":"Messex JK, Liou G-Y. Impact of immune cells in the tumor microenvironment of prostate cancer metastasis. Life. 2023\/1\/26;13(2):333. https:\/\/doi.org\/10.3390\/life13020333.","journal-title":"Life"},{"issue":"1","key":"8074_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12865-022-00514-3","volume":"23","author":"Y Peng","year":"2022","unstructured":"Peng Y, Zhao M, Hu Y, et al. Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer. BMC Immunol. 2022\/8\/8;23(1):37. https:\/\/doi.org\/10.1186\/s12865-022-00514-3.","journal-title":"BMC Immunol"},{"issue":"9","key":"8074_CR48","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.3390\/cancers12092718","volume":"12","author":"J Gwak","year":"2020","unstructured":"Gwak J, Jeong H, Lee K, et al. SFMBT2-mediated infiltration of preadipocytes and TAMs in prostate cancer. Cancers. 2020\/9\/22;12(9):2718. https:\/\/doi.org\/10.3390\/cancers12092718.","journal-title":"Cancers"},{"key":"8074_CR49","doi-asserted-by":"publisher","unstructured":"Masetti M, Carriero R, Portale F, et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. The J Exp Med. 2022\/2\/7;219(2):e20210564. https:\/\/doi.org\/10.1084\/jem.20210564.","DOI":"10.1084\/jem.20210564"},{"key":"8074_CR50","doi-asserted-by":"publisher","first-page":"566511","DOI":"10.3389\/fonc.2020.566511","volume":"10","author":"I Larionova","year":"2020","unstructured":"Larionova I, Tuguzbaeva G, Ponomaryova A, et al. Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate Cancers. Front Oncol. 2020\/10\/22;10:566511. https:\/\/doi.org\/10.3389\/fonc.2020.566511.","journal-title":"Front Oncol"},{"issue":"8","key":"8074_CR51","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/membranes12080775","volume":"12","author":"M La","year":"2022","unstructured":"La M, Song K, Li S, Kang Y. Exosomes: small vesicles with important roles in the development, metastasis and treatment of breast cancer. Membranes (Basel). 2022\/8\/12;12(8):775. https:\/\/doi.org\/10.3390\/membranes12080775.","journal-title":"Membranes (Basel)"},{"key":"8074_CR52","doi-asserted-by":"publisher","unstructured":"Liu Y, Lu M, Liu F, et al. Extracellular vesicles obtained from Lung adenocarcinoma cells culture d under intermittent hypoxia induce M2 macrophage polarization via miR -20a-5p delivery. Technol Cancer Res Treat. 2024\/1;23. https:\/\/doi.org\/10.1177\/15330338231219415.","DOI":"10.1177\/15330338231219415"},{"issue":"8","key":"8074_CR53","doi-asserted-by":"publisher","first-page":"101112","DOI":"10.1016\/j.tranon.2021.101112","volume":"14","author":"Y Wu","year":"2021","unstructured":"Wu Y, Brennan K, Fern\u00e1ndez AB, Mc Gee MM. Cyclophilin a regulates secretion of tumour-derived extracellular vesicles. Transl Oncol. 2021\/8;14(8):101112. https:\/\/doi.org\/10.1016\/j.tranon.2021.101112.","journal-title":"Transl Oncol"},{"key":"8074_CR54","doi-asserted-by":"publisher","unstructured":"Reed T, Schorey J, D\u2019Souza-Schorey C. Tumor-derived extracellular vesicles: a means of co-opting macrophage polarization in the tumor microenvironment. Front. Cell Dev. Biol. 2021\/10\/8;9. https:\/\/doi.org\/10.3389\/fcell.2021.746432.","DOI":"10.3389\/fcell.2021.746432"},{"key":"8074_CR55","doi-asserted-by":"publisher","first-page":"640355","DOI":"10.3389\/fmolb.2021.640355","volume":"8","author":"AT Srivatsav","year":"2021","unstructured":"Srivatsav AT, Kapoor S. The Emerging world of membrane vesicles: functional relevance, therapeutic avenues and tools for Investigating membrane function. Front Mol Biosci. 2021\/4\/22;8:640355. https:\/\/doi.org\/10.3389\/fmolb.2021.640355.","journal-title":"Front Mol Biosci"},{"key":"8074_CR56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fimmu.2016.00173","volume":"7","author":"V Rebmann","year":"2016","unstructured":"Rebmann V, K\u00f6nig L, FdS N, Wagner B, Manvailer LFS, Horn PA. The potential of HLA-G-Bearing extracellular vesicles as a future element in HLA-G immune biology. Front Immunol. 2016 May 4;7:173. https:\/\/doi.org\/10.3389\/fimmu.2016.00173.","journal-title":"Front Immunol"},{"key":"8074_CR57","doi-asserted-by":"publisher","unstructured":"Correll VL, Otto JJ, Risi CM, et al. Optimization of small extracellular vesicle isolation from expressed prostatic secretions in urine for in-depth proteomic analysis. J Extracell Vesicles. 2022\/2;11(2):e12184. https:\/\/doi.org\/10.1002\/jev2.12184.","DOI":"10.1002\/jev2.12184"},{"issue":"1737","key":"8074_CR58","doi-asserted-by":"publisher","first-page":"20160488","DOI":"10.1098\/rstb.2016.0488","volume":"373","author":"A O\u2019Loghlen","year":"2017","unstructured":"O\u2019Loghlen A. Role for extracellular vesicles in the tumour microenvironment. Phil Trans R Soc B. 2017\/11\/20;373(1737):20160488. https:\/\/doi.org\/10.1098\/rstb.2016.0488.","journal-title":"Phil Trans R Soc B"},{"issue":"1","key":"8074_CR59","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s12951-024-02863-0","volume":"22","author":"H Tang","year":"2024","unstructured":"Tang H, Yu D, Zhang J, et al. The new advance of exosome-based liquid biopsy for cancer diagnosis. J Nanobiotechnol. 2024\/10\/8;22(1):610. https:\/\/doi.org\/10.1186\/s12951-024-02863-0.","journal-title":"J Nanobiotechnol"},{"issue":"16","key":"8074_CR60","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.3390\/jcm11164932","volume":"11","author":"H Al-Koussa","year":"2022","unstructured":"Al-Koussa H, AlZaim I, El-Sabban ME. Pathophysiology of Coagulation and Emerging roles for extracellular vesicles in Coagulation cascades and disorders. JCM. 2022\/8\/22;11(16):4932. https:\/\/doi.org\/10.3390\/jcm11164932.","journal-title":"JCM"},{"issue":"10","key":"8074_CR61","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1016\/j.apsb.2022.05.002","volume":"12","author":"S Liu","year":"2022","unstructured":"Liu S, Wu X, Chandra S, et al. Extracellular vesicles: emerging tools as therapeutic agent carriers. Acta Pharm Sin B. 2022\/10;12(10):3822\u201342. https:\/\/doi.org\/10.1016\/j.apsb.2022.05.002.","journal-title":"Acta Pharm Sin B"},{"key":"8074_CR62","doi-asserted-by":"publisher","unstructured":"Alipoor SD, Mortaz E, Varahram M, et al. The potential biomarkers and immunological effects of tumor-derived exosomes in Lung cancer. Front Immunol. 2018\/4\/18;. https:\/\/doi.org\/10.3389\/fimmu.2018.00819.","DOI":"10.3389\/fimmu.2018.00819"},{"issue":"17","key":"8074_CR63","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1039\/d1lc00443c","volume":"21","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Y, Yan H, et al. Advances in microfluidic extracellular vesicle analysis for cancer diagnostics. Lab Chip. 2021;21(17):3219\u201343. https:\/\/doi.org\/10.1039\/d1lc00443c.","journal-title":"Lab Chip"},{"key":"8074_CR64","doi-asserted-by":"publisher","unstructured":"Li Q, Zhang Z, Wang F, et al. Reversible zwitterionic coordination enables rapid, high-yield, and high-purity isolation of extracellular vesicles from biofluids. Sci Adv. 2023\/4\/14;9(15). https:\/\/doi.org\/10.1126\/sciadv.adf4568.","DOI":"10.1126\/sciadv.adf4568"},{"issue":"1","key":"8074_CR65","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12943-025-02282-1","volume":"24","author":"A Semeradtova","year":"2025","unstructured":"Semeradtova A, Liegertova M, Herma R, Capkova M, Brignole C, Del Zotto G. Extracellular vesicles in cancer\u00b4s communication: messages we can read and how to answer. Mol Cancer. 2025\/3\/19;24(1):86. https:\/\/doi.org\/10.1186\/s12943-025-02282-1.","journal-title":"Mol Cancer"},{"issue":"5","key":"8074_CR66","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3390\/pharmaceutics15051551","volume":"15","author":"S Mansur","year":"2023","unstructured":"Mansur S, Habib S, Hawkins M, Brown SR, Weinman ST, Bao Y. Preparation of nanoparticle-loaded extracellular vesicles using direct flow filtration. Pharmaceutics. 2023\/5\/20;15(5):1551. https:\/\/doi.org\/10.3390\/pharmaceutics15051551.","journal-title":"Pharmaceutics"},{"issue":"1","key":"8074_CR67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12929-025-01182-2","volume":"32","author":"NY Yeat","year":"2025","unstructured":"Yeat NY, Chen R-H. Extracellular vesicles: biogenesis mechanism and impacts on tumor immune microenvironment. J Biomed Sci. 2025\/9\/4;32(1):85. https:\/\/doi.org\/10.1186\/s12929-025-01182-2.","journal-title":"J Biomed Sci"},{"issue":"1","key":"8074_CR68","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/biology12010110","volume":"12","author":"M Sheta","year":"2023","unstructured":"Sheta M, Taha EA, Lu Y, Eguchi T. Extracellular vesicles: new classification and tumor immunosuppression. Biol (Basel). 2023\/1\/10;12(1):110. https:\/\/doi.org\/10.3390\/biology12010110.","journal-title":"Biol (Basel)"},{"issue":"2","key":"8074_CR69","doi-asserted-by":"publisher","first-page":"166917","DOI":"10.1016\/j.bbadis.2023.166917","volume":"1870","author":"L Niu","year":"2024","unstructured":"Niu L, Wang Q, Feng F, et al. Small extracellular vesicles-mediated cellular interactions between tumor cells and tumor-associated macrophages: implication for immunotherapy. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2024\/2;1870(2):166917. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166917.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"1","key":"8074_CR70","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12951-023-02105-9","volume":"21","author":"B Liu","year":"2023","unstructured":"Liu B, Nguyen PL, Yu H, et al. Critical contributions of protein cargos to the functions of macrophage-derived extracellular vesicles. J Nanobiotechnol. 2023\/9\/28;21(1):352. https:\/\/doi.org\/10.1186\/s12951-023-02105-9.","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"8074_CR71","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/biomedicines12071473","volume":"12","author":"A Biondi","year":"2024","unstructured":"Biondi A, Vacante M, Catania R, Sangiorgio G. Extracellular vesicles and immune System function: exploring novel approaches to colorectal cancer immunotherapy. Biomedicines. 2024\/7\/3;12(7):1473. https:\/\/doi.org\/10.3390\/biomedicines12071473.","journal-title":"Biomedicines"},{"issue":"10","key":"8074_CR72","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3390\/biology14101371","volume":"14","author":"VG Yuan","year":"2025","unstructured":"Yuan VG. Polarized macrophages and their exosomes: implications for autoimmune and immune-mediated Diseases. Biol (Basel). 2025\/10\/8;14(10):1371. https:\/\/doi.org\/10.3390\/biology14101371.","journal-title":"Biol (Basel)"},{"key":"8074_CR73","doi-asserted-by":"publisher","unstructured":"Tian J-W, Fang Y-H, Zhang H-J, Yu Z-L. The dual effects of macrophage-derived extracellular vesicles on tumor cell behavior: mechanisms and clinical potential. Front Oncol. 2025\/5\/23;15. https:\/\/doi.org\/10.3389\/fonc.2025.1586083.","DOI":"10.3389\/fonc.2025.1586083"},{"key":"8074_CR74","doi-asserted-by":"publisher","unstructured":"Pantazi P, Clements T, Ven\u00f8 M, Abrahams VM, Holder B. Distinct non-coding RNA cargo of extracellular vesicles from M1 and M2 human primary macrophages. J Extracell Vesicles. 2022\/12;11(12). https:\/\/doi.org\/10.1002\/jev2.12293.","DOI":"10.1002\/jev2.12293"},{"issue":"17","key":"8074_CR75","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.3390\/ijms21176001","volume":"21","author":"L Gambari","year":"2020","unstructured":"Gambari L, Grassi F, Roseti L, Grigolo B, Desando G. Learning from Monocyte-macrophage fusion and multinucleation: potential therapeutic targets for osteoporosis and rheumatoid arthritis. Int J Mol Sci. 2020\/8\/20;21(17):6001. https:\/\/doi.org\/10.3390\/ijms21176001.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"8074_CR76","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.3390\/ijms21113989","volume":"21","author":"NC Smith","year":"2020","unstructured":"Smith NC, Christian SL, Woldemariam NT, Clow KA, Rise ML, Andreassen R. Characterization of miRnas in cultured atlantic salmon Head Kidney Monocyte-like and macrophage-like cells. Int J Mol Sci. 2020\/6\/2;21(11):3989. https:\/\/doi.org\/10.3390\/ijms21113989.","journal-title":"Int J Mol Sci"},{"key":"8074_CR77","doi-asserted-by":"publisher","unstructured":"Cheng R, Li S, Ma X, et al. Intratumoral antigen-presenting cell activation by a nanovesicle for the concurrent tertiary lymphoid structure de novo neogenesis. Sci Adv. 2025\/2\/21;11(8):eadr1299. https:\/\/doi.org\/10.1126\/sciadv.adr1299.","DOI":"10.1126\/sciadv.adr1299"},{"key":"8074_CR78","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12935-020-1163-9","volume":"20","author":"F Yang","year":"2020","unstructured":"Yang F, Wang T, Du P, Fan H, Dong X, Guo H. M2 bone marrow-derived macrophage-derived exosomes shuffle microRNA-21 to accelerate immune escape of glioma by modulating PEG3. Cancer Cell Int. 2020\/3\/27;20:93. https:\/\/doi.org\/10.1186\/s12935-020-1163-9.","journal-title":"Cancer Cell Int"},{"key":"8074_CR79","doi-asserted-by":"publisher","unstructured":"Song L, Yu X, Wu Y, et al. Integrin \u03b28 facilitates macrophage infiltration and polarization by regulating CCL5 to promote LUAD progression. Adv Sci. 2024\/11\/13;12(2). https:\/\/doi.org\/10.1002\/advs.202406865.","DOI":"10.1002\/advs.202406865"},{"issue":"12","key":"8074_CR80","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.4251\/wjgo.v13.i12.2013","volume":"13","author":"L Lu","year":"2021","unstructured":"Lu L, Liu Y-J, Cheng P-Q, Dan H, Xu H-C, Ji G. Macrophages play a role in inflammatory transformation of colorectal cancer. WJGO. 2021\/12\/15;13(12):2013\u201328. https:\/\/doi.org\/10.4251\/wjgo.v13.i12.2013.","journal-title":"WJGO"},{"key":"8074_CR81","doi-asserted-by":"publisher","unstructured":"Wu X, Tang N, Zhao Q, Xiong J. Spatiotemporal evolutionary process of osteosarcoma immune microenvironment remodeling and >scp>C1QBP-driven>\/scp> drug resistance deciphered through >scp>single-cell multi-dimensional<\/scp> analysis. Bioeng & Transla Med. 2024\/4\/10;9(5). https:\/\/doi.org\/10.1002\/btm2.10654.","DOI":"10.1002\/btm2.10654"},{"issue":"6","key":"8074_CR82","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.apsb.2020.12.014","volume":"11","author":"Q Hu","year":"2021","unstructured":"Hu Q, Lyon CJ, Fletcher JK, Tang W, Wan M, Hu TY. Extracellular vesicle activities regulating macrophage- and tissue-mediated injury and repair responses. Acta Pharm Sin B. 2021\/6;11(6):1493\u2013512. https:\/\/doi.org\/10.1016\/j.apsb.2020.12.014.","journal-title":"Acta Pharm Sin B"},{"key":"8074_CR83","doi-asserted-by":"publisher","unstructured":"Tian H-Y, Liang Q, Shi Z, Zhao H. Exosomal CXCL14 contributes to M2 macrophage polarization through NF-\u03baB signaling in prostate cancer. Oxid Med Cell Longev. 2022;7616696. https:\/\/doi.org\/10.1155\/2022\/7616696.","DOI":"10.1155\/2022\/7616696"},{"issue":"6","key":"8074_CR84","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.7150\/jca.81933","volume":"14","author":"W Xu","year":"2023","unstructured":"Xu W, Lu M, Xie S, Zhou D, Zhu M, Liang C. Endoplasmic reticulum stress promotes prostate cancer cells to release exosome and up-regulate PD-L1 expression via PI3K\/Akt signaling pathway in macrophages. J Cancer. 2023\/4\/17;14(6):1062\u201374. https:\/\/doi.org\/10.7150\/jca.81933.","journal-title":"J Cancer"},{"key":"8074_CR85","doi-asserted-by":"publisher","first-page":"1021270","DOI":"10.3389\/fonc.2022.1021270","volume":"12","author":"H Guan","year":"2022","unstructured":"Guan H, Mao L, Wang J, et al. Exosomal RNF157 mRNA from prostate cancer cells contributes to M2 macrophage polarization through destabilizing HDAC1. Front Oncol. 2022\/10\/3;12:1021270. https:\/\/doi.org\/10.3389\/fonc.2022.1021270.","journal-title":"Front Oncol"},{"issue":"8048","key":"8074_CR86","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","volume":"637","author":"A Lyu","year":"2024","unstructured":"Lyu A, Fan Z, Clark M, et al. Evolution of myeloid-mediated immunotherapy resistance in prostate cancer. Nature. 2024\/12\/4;637(8048):1207\u201317. https:\/\/doi.org\/10.1038\/s41586-024-08290-3.","journal-title":"Nature"},{"issue":"1","key":"8074_CR87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13046-017-0528-y","volume":"36","author":"P Zheng","year":"2017","unstructured":"Zheng P, Chen L, Yuan X, et al. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. J Exp Clin Cancer Res. 2017\/4\/13;36(1):53. https:\/\/doi.org\/10.1186\/s13046-017-0528-y.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"8074_CR88","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4149\/neo_2017_311","volume":"64","author":"M Korabecna","year":"2017","unstructured":"Korabecna M, Koutova L, Tesarova P. The potential roles of vesicle-enclosed miRNAs in communication between macrophages and cancer cells in tumor microenvironment. Neoplasma. 2017;64(3):406\u201311. https:\/\/doi.org\/10.4149\/neo_2017_311.","journal-title":"Neoplasma"},{"issue":"1","key":"8074_CR89","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12964-024-01473-5","volume":"22","author":"B Wang","year":"2024","unstructured":"Wang B, Cheng D, Ma D, et al. Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes. Cell Commun Signal. 2024\/1\/9;22(1):21. https:\/\/doi.org\/10.1186\/s12964-024-01473-5.","journal-title":"Cell Commun Signal"},{"key":"8074_CR90","doi-asserted-by":"publisher","unstructured":"Wang L, Wang W, Hu D, et al. Tumor-derived extracellular vesicles regulate macrophage polarization: role and therapeutic perspectives. Front Immunol. 2024\/4\/16;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1346587.","DOI":"10.3389\/fimmu.2024.1346587"},{"key":"8074_CR91","doi-asserted-by":"publisher","first-page":"103093","DOI":"10.1016\/j.redox.2024.103093","volume":"71","author":"A Schwantes","year":"2024","unstructured":"Schwantes A, Wickert A, Becker S, et al. Tumor associated macrophages transfer ceruloplasmin mRNA to fibrosarcoma cells and protect them from ferroptosis. Redox Biol. 2024\/5;71:103093. https:\/\/doi.org\/10.1016\/j.redox.2024.103093.","journal-title":"Redox Biol"},{"issue":"7","key":"8074_CR92","doi-asserted-by":"publisher","first-page":"203","DOI":"10.31083\/j.fbl2707203","volume":"27","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Xu B, Hu N, et al. Targeting the macrophage-ferroptosis crosstalk: a novel insight into tumor immunotherapy. Front Biosci (Landmark Ed). 2022\/6\/27;27(7):203. https:\/\/doi.org\/10.31083\/j.fbl2707203.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"8074_CR93","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13062-024-00560-4","volume":"19","author":"X Huang","year":"2024","unstructured":"Huang X, Yi N, Zhu P, Gao J, Lv J. Sorafenib-induced macrophage extracellular traps via ARHGDIG\/IL4\/PADI4 axis confer drug resistance through inhibiting ferroptosis in hepatocellular carcinoma. Biol Direct. 2024\/11\/11;19(1):110. https:\/\/doi.org\/10.1186\/s13062-024-00560-4.","journal-title":"Biol Direct"},{"issue":"1","key":"8074_CR94","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1530\/ERC-18-0284","volume":"26","author":"W Guan","year":"2019","unstructured":"Guan W, Hu J, Yang L, et al. Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer. Endocr Relat Cancer. 2019\/1\/1;26(1):131\u201340. https:\/\/doi.org\/10.1530\/ERC-18-0284.","journal-title":"Endocr Relat Cancer"},{"key":"8074_CR95","doi-asserted-by":"publisher","first-page":"104348","DOI":"10.1016\/j.critrevonc.2024.104348","volume":"197","author":"C Liao","year":"2024","unstructured":"Liao C, Huang Z, Liu J, et al. Role of extracellular vesicles in castration-resistant prostate cancer. Crit Rev Oncol\/Hematol. 2024\/5;197:104348. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104348.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"15","key":"8074_CR96","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.3390\/cancers13153791","volume":"13","author":"C Saldana","year":"2021","unstructured":"Saldana C, Majidipur A, Beaumont E, et al. Extracellular vesicles in advanced prostate cancer: tools to predict a nd thwart therapeutic resistance. Cancers. 2021\/7\/28;13(15):3791. https:\/\/doi.org\/10.3390\/cancers13153791.","journal-title":"Cancers"},{"issue":"1","key":"8074_CR97","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1186\/s12951-025-03763-7","volume":"23","author":"Q Sheng","year":"2025","unstructured":"Sheng Q, Wu Z, Li W, et al. Extracellular vesicles in metabolic perspective: mechanism and targeted therapy. J Nanobiotechnol. 2025\/10\/14;23(1):676. https:\/\/doi.org\/10.1186\/s12951-025-03763-7.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"8074_CR98","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1111\/cas.15771","volume":"114","author":"M Otsuka","year":"2023","unstructured":"Otsuka M, Kotani A. Recent advances in extracellular vesicles in gastrointestinal cancer a nd lymphoma. Cancer Sci. 2023\/6;114(6):2230\u201337. https:\/\/doi.org\/10.1111\/cas.15771.","journal-title":"Cancer Sci"},{"issue":"8","key":"8074_CR99","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3390\/cancers14081865","volume":"14","author":"R Carles-Fontana","year":"2022","unstructured":"Carles-Fontana R, Heaton N, Palma E, Khorsandi S. Extracellular vesicle-mediated mitochondrial reprogramming in cancer. Cancers. 2022\/4\/7;14(8):1865. https:\/\/doi.org\/10.3390\/cancers14081865.","journal-title":"Cancers"},{"issue":"3","key":"8074_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0218-2","volume":"51","author":"R Bandu","year":"2019","unstructured":"Bandu R, Oh JW, Kim KP. Mass spectrometry-based proteome profiling of extracellular vesicles a nd their roles in cancer biology. Exp & Mol Med. 2019\/3;51(3):1\u201310. https:\/\/doi.org\/10.1038\/s12276-019-0218-2.","journal-title":"Exp & Mol Med"},{"issue":"3","key":"8074_CR101","doi-asserted-by":"publisher","first-page":"913","DOI":"10.4049\/jimmunol.2100230","volume":"207","author":"SL Collins","year":"2021","unstructured":"Collins SL, Oh M-H, Sun I-H, et al. mTORC1 signaling regulates proinflammatory macrophage function and metabolism. J Immunol. 2021\/8\/1;207(3):913\u201322. https:\/\/doi.org\/10.4049\/jimmunol.2100230.","journal-title":"J Immunol"},{"issue":"20","key":"8074_CR102","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1097\/cm9.0000000000002426","volume":"135","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang D, Yang L, Zhang Y. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages. Chin Med J. 2022\/10\/20;135(20):2405\u201316. https:\/\/doi.org\/10.1097\/cm9.0000000000002426.","journal-title":"Chin Med J"},{"issue":"1","key":"8074_CR103","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10238-026-02055-0","volume":"26","author":"A Salmaninejad","year":"2026","unstructured":"Salmaninejad A, Layeghi SM, Falakian Z, et al. The role of tumor-associated macrophages in cancer development and their significance as prognostic markers. Clin Exp Med. 2026\/2\/16;26(1):155. https:\/\/doi.org\/10.1007\/s10238-026-02055-0.","journal-title":"Clin Exp Med"},{"key":"8074_CR104","doi-asserted-by":"publisher","first-page":"631703","DOI":"10.3389\/fonc.2021.631703","volume":"11","author":"T Su","year":"2021","unstructured":"Su T, Zhang P, Zhao F, Zhang S. Exosomal MicroRNAs mediating crosstalk between cancer cells with cancer-associated fibroblasts and tumor-associated macrophages in the tumor microenvironment. Front Oncol. 2021\/4\/1;11:631703. https:\/\/doi.org\/10.3389\/fonc.2021.631703.","journal-title":"Front Oncol"},{"key":"8074_CR105","doi-asserted-by":"publisher","unstructured":"Zhou M, He X, Mei C, Ou C. Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers. Biomark Res. 2023\/11\/19;11(1). https:\/\/doi.org\/10.1186\/s40364-023-00538-w.","DOI":"10.1186\/s40364-023-00538-w"},{"issue":"4","key":"8074_CR106","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10555-024-10210-w","volume":"43","author":"P Limonta","year":"2024","unstructured":"Limonta P, Marchesi S, Giannitti G, Casati L, Fontana F. The biological function of extracellular vesicles in prostate cancer and their clinical application as diagnostic and prognostic biomarkers. Cancer Metastasis Rev. 2024;43(4):1611\u201327. https:\/\/doi.org\/10.1007\/s10555-024-10210-w.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"8074_CR107","doi-asserted-by":"publisher","first-page":"24230","DOI":"10.1038\/s41598-024-75265-9","volume":"14","author":"E Heninger","year":"2024","unstructured":"Heninger E, Breneman MT, Recchia EE, et al. Dynamic reciprocal interactions between activated T cells and tumor-associated macrophages drive macrophage reprogramming and proinflammatory T cell migration within prostate tumor models. Sci Rep. 2024\/10\/16;14(1):24230. https:\/\/doi.org\/10.1038\/s41598-024-75265-9.","journal-title":"Sci Rep"},{"issue":"1","key":"8074_CR108","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wang J, Lu D, Xu X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Targeted Ther. 2021\/2\/23;6(1):75. https:\/\/doi.org\/10.1038\/s41392-021-00484-9.","journal-title":"Signal Transduct Targeted Ther"},{"key":"8074_CR109","doi-asserted-by":"publisher","unstructured":"Kim S-J, Khadka D, Seo JH. Interplay between solid tumors and tumor microenvironment. Front Immunol. 2022\/5\/30;13. https:\/\/doi.org\/10.3389\/fimmu.2022.882718.","DOI":"10.3389\/fimmu.2022.882718"},{"issue":"42","key":"8074_CR110","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.3760\/cma.j.issn.0376-2491.2019.42.003","volume":"99","author":"TS Zhai","year":"2019","unstructured":"Zhai TS, Jin L, Zhou Z, et al. The concept of tumor-derived exosomes and research progress in bone metastasis of prostate cancer. Zhonghua Yi Xue Za Zhi. 2019\/11\/12;99(42):3288\u201391. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2019.42.003.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"8074_CR111","doi-asserted-by":"publisher","unstructured":"Tai Y-L, Lin C-J, Li T-K, Shen T-L, Hsieh J-T, Chen BPC. The role of extracellular vesicles in prostate cancer with clinical applications. Endocr Relat Cancer. 2020\/5;27(5):R133\u201344. https:\/\/doi.org\/10.1530\/erc-20-0021.","DOI":"10.1530\/erc-20-0021"},{"issue":"9","key":"8074_CR112","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3390\/cancers11091276","volume":"11","author":"L Mezzasoma","year":"2019","unstructured":"Mezzasoma L, Costanzi E, Scarpelli P, Talesa VN, Bellezza I. Extracellular vesicles from human advanced-stage prostate cancer cells modify the inflammatory response of microenvironment-residing cells. Cancers. 2019\/8\/30;11(9):1276. https:\/\/doi.org\/10.3390\/cancers11091276.","journal-title":"Cancers"},{"issue":"16","key":"8074_CR113","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/0008-5472.can-17-3841","volume":"78","author":"X Wang","year":"2018","unstructured":"Wang X, Luo G, Zhang K, et al. Hypoxic tumor-derived Exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3K\u03b3 to promote pancreatic cancer metastasis. Cancer Res. 2018\/8\/14;78(16):4586\u201398. https:\/\/doi.org\/10.1158\/0008-5472.can-17-3841.","journal-title":"Cancer Res"},{"issue":"5","key":"8074_CR114","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/cancers16050923","volume":"16","author":"TM J\u00f3\u017awicka","year":"2024","unstructured":"J\u00f3\u017awicka TM, Erdma\u0144ska PM, Stachowicz-Karpi\u0144ska A, Olkiewicz M, J\u00f3\u017awicki W. Exosomes-promising carriers for regulatory therapy in oncology. Cancers. 2024\/2\/25;16(5):923. https:\/\/doi.org\/10.3390\/cancers16050923.","journal-title":"Cancers"},{"key":"8074_CR115","doi-asserted-by":"publisher","unstructured":"Nail HM, Chiu C-C, Leung C-H, Ahmed MMM, Wang H-M. Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments. J Biomed Sci. 2023\/8\/21;30(1). https:\/\/doi.org\/10.1186\/s12929-023-00964-w.","DOI":"10.1186\/s12929-023-00964-w"},{"key":"8074_CR116","doi-asserted-by":"publisher","unstructured":"Tan S, Tang H, Wang Y, et al. Tumor cell-derived exosomes regulate macrophage polarization: emerging directions in the study of tumor genesis and development. Heliyon. 2023\/9;9(9):e19296. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19296.","DOI":"10.1016\/j.heliyon.2023.e19296"},{"issue":"12","key":"8074_CR117","doi-asserted-by":"publisher","first-page":"9729","DOI":"10.1002\/jcp.29784","volume":"235","author":"H Guan","year":"2020","unstructured":"Guan H, Peng R, Fang F, et al. Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer. J Cell Physiol. 2020\/12;235(12):9729\u201342. https:\/\/doi.org\/10.1002\/jcp.29784.","journal-title":"J Cell Physiol"},{"issue":"1","key":"8074_CR118","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12672-025-02195-x","volume":"16","author":"X Hu","year":"2025","unstructured":"Hu X, Li Y, Wang X, Xue X. Role of M2 macrophage-derived exosomes in cancer drug resistance via noncoding RNAs. Discover Oncol. 2025\/5\/12;16(1):741. https:\/\/doi.org\/10.1007\/s12672-025-02195-x.","journal-title":"Discover Oncol"},{"issue":"6","key":"8074_CR119","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1007\/s11010-025-05222-1","volume":"480","author":"H Guan","year":"2025","unstructured":"Guan H, Tao H, Luo J, et al. Upregulation of YY1 in M2 macrophages promotes secretion of exosomes containing hsa-circ-0000326 via super-enhancers to facilitate prostate cancer progression. Mol Cell Biochem. 2025\/6;480(6):3873\u201388. https:\/\/doi.org\/10.1007\/s11010-025-05222-1.","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"8074_CR120","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3779\/j.issn.1009-3419.2022.102.33","volume":"25","author":"N Wang","year":"2022","unstructured":"Wang N, Song X. Research advances of immunotherapy of exosome PD-L1 in non-small cell Lung cancer. Zhongguo Fei Ai Za Zhi. 2022\/9\/20;25(9):689\u201395. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2022.102.33.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"8074_CR121","doi-asserted-by":"publisher","first-page":"980433","DOI":"10.3389\/fmolb.2023.980433","volume":"10","author":"C Bajo-Santos","year":"2023","unstructured":"Bajo-Santos C, Brok\u0101ne A, Zayakin P, et al. Plasma and urinary extracellular vesicles as a source of RNA biomarkers for prostate cancer in liquid biopsies. Front Mol Biosci. 2023\/2\/3;10:980433. https:\/\/doi.org\/10.3389\/fmolb.2023.980433.","journal-title":"Front Mol Biosci"},{"key":"8074_CR122","doi-asserted-by":"publisher","unstructured":"Bryzgunova OE, Zaripov MM, Skvortsova TE, et al. Comparative study of extracellular vesicles from the urine of healthy individuals and prostate cancer patients. PLoS One. 2016\/6\/15;11(6):e0157566. https:\/\/doi.org\/10.1371\/journal.pone.0157566.","DOI":"10.1371\/journal.pone.0157566"},{"issue":"4","key":"8074_CR123","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.21037\/tau-20-1210","volume":"10","author":"K Hatano","year":"2021","unstructured":"Hatano K, Fujita K. Extracellular vesicles in prostate cancer: a narrative review. Transl Androl Urol. 2021\/4;10(4):1890\u2013907. https:\/\/doi.org\/10.21037\/tau-20-1210.","journal-title":"Transl Androl Urol"},{"key":"8074_CR124","doi-asserted-by":"publisher","first-page":"149662","DOI":"10.1016\/j.gene.2025.149662","volume":"965","author":"J Marianna Kruithof-de","year":"2025","unstructured":"Marianna Kruithof-de J. Elevating prostate cancer diagnostics through extracellular vesicle miRNAs. Gene. 2025\/9\/15;965:149662. https:\/\/doi.org\/10.1016\/j.gene.2025.149662.","journal-title":"Gene"},{"issue":"8","key":"8074_CR125","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.62347\/QYZS2620","volume":"14","author":"MY Kim","year":"2024","unstructured":"Kim MY, Moon HW, Jo MS, Lee JY. Exosomal miR-664a-5p as a therapeutic target biomarker for PARP inhibitor response in prostate cancer. Am J Cancer Res. 2024\/8\/25;14(8):3789\u201399. https:\/\/doi.org\/10.62347\/QYZS2620.","journal-title":"Am J Cancer Res"},{"key":"8074_CR126","doi-asserted-by":"publisher","unstructured":"Oey O, Ghaffari M, Li JJ, Hosseini-Beheshti E. Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: implications for clinical practice. Crit Rev Oncol\/Hematol. 2021\/11;167(103495). https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103495.","DOI":"10.1016\/j.critrevonc.2021.103495"},{"issue":"14","key":"8074_CR127","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.3390\/ijms26146895","volume":"26","author":"S Lange","year":"2025","unstructured":"Lange S, Bernstein DE, Dimov N, et al. Urinary extracellular vesicle signatures as biomarkers in prostate cancer patients. Int J Mol Sci. 2025\/7\/18;26(14):6895. https:\/\/doi.org\/10.3390\/ijms26146895.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"8074_CR128","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41416-024-02829-x","volume":"131","author":"BD Nturubika","year":"2024","unstructured":"Nturubika BD, Guardia CM, Gershlick DC, et al. Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression. Br J Cancer. 2024\/11;131(8):1263\u201378. https:\/\/doi.org\/10.1038\/s41416-024-02829-x.","journal-title":"Br J Cancer"},{"issue":"2","key":"8074_CR129","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/proteomes10020012","volume":"10","author":"E Shaba","year":"2022","unstructured":"Shaba E, Vantaggiato L, Governini L, et al. Multi-omics integrative approach of extracellular vesicles: a future challenge milestone. Proteomes. 2022\/4\/22;10(2):12. https:\/\/doi.org\/10.3390\/proteomes10020012.","journal-title":"Proteomes"},{"issue":"24","key":"8074_CR130","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.3390\/cancers16244261","volume":"16","author":"AT Arafa","year":"2024","unstructured":"Arafa AT, Ludwig M, Tuncer O, et al. Isolation of plasma extracellular vesicles for high-depth analysis of proteomic biomarkers in metastatic castration-resistant prostate cancer patients. Cancers. 2024\/12\/21;16(24):4261. https:\/\/doi.org\/10.3390\/cancers16244261.","journal-title":"Cancers"},{"issue":"2","key":"8074_CR131","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/ijms17020170","volume":"17","author":"H Kalra","year":"2016","unstructured":"Kalra H, Drummen GPC, Mathivanan S. Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci. 2016\/2\/6;17(2):170. https:\/\/doi.org\/10.3390\/ijms17020170.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"8074_CR132","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/nano15181418","volume":"15","author":"K Mediratta","year":"2025","unstructured":"Mediratta K, Diab MD, Han P, Hu H, Wang L. Emerging strategies for cargo loading and engineering of extracellular vesicles for breast cancer treatment. Nanomaterials. 2025\/9\/15;15(18):1418. https:\/\/doi.org\/10.3390\/nano15181418.","journal-title":"Nanomaterials"},{"issue":"1","key":"8074_CR133","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12951-023-02219-0","volume":"21","author":"H Chen","year":"2023","unstructured":"Chen H, Pang B, Zhou C, et al. Prostate cancer-derived small extracellular vesicle proteins: the hope in diagnosis, prognosis, and therapeutics. J Nanobiotechnol. 2023\/12\/14;21(1):480. https:\/\/doi.org\/10.1186\/s12951-023-02219-0.","journal-title":"J Nanobiotechnol"},{"key":"8074_CR134","doi-asserted-by":"publisher","unstructured":"Lou K, Feng S, Luo H, Zou J, Zhang G, Zou X. Extracellular vesicles derived from macrophages: current applications and prospects in tumors. Front Bioeng Biotechnol. 2022\/12\/15;10. https:\/\/doi.org\/10.3389\/fbioe.2022.1097074.","DOI":"10.3389\/fbioe.2022.1097074"},{"issue":"11","key":"8074_CR135","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.3390\/cancers14112635","volume":"14","author":"R Ishikawa","year":"2022","unstructured":"Ishikawa R, Yoshida S, S-I S, Sasaki Y, Akiyoshi K. Fusogenic hybrid extracellular vesicles with PD-1 membrane proteins for the cytosolic delivery of cargos. Cancers. 2022\/5\/26;14(11):2635. https:\/\/doi.org\/10.3390\/cancers14112635.","journal-title":"Cancers"},{"key":"8074_CR136","doi-asserted-by":"publisher","first-page":"216107","DOI":"10.1016\/j.canlet.2023.216107","volume":"558","author":"C Ducrot","year":"2023","unstructured":"Ducrot C, Loiseau S, Wong C, Madec E, Volatron J, Piffoux M. Hybrid extracellular vesicles for drug delivery. Cancer Lett. 2023\/4;558:216107. https:\/\/doi.org\/10.1016\/j.canlet.2023.216107.","journal-title":"Cancer Lett"},{"key":"8074_CR137","doi-asserted-by":"publisher","first-page":"113974","DOI":"10.1016\/j.addr.2021.113974","volume":"178","author":"J Wang","year":"2021","unstructured":"Wang J, Zhu M, Nie G. Biomembrane-based nanostructures for cancer targeting and therapy: from synthetic liposomes to natural biomembranes and membrane-vesicles. Adv Drug Deliv Rev. 2021\/11;178:113974. https:\/\/doi.org\/10.1016\/j.addr.2021.113974.","journal-title":"Adv Drug Deliv Rev"},{"key":"8074_CR138","doi-asserted-by":"publisher","unstructured":"Evers MJW, van de Wakker SI, de Groot EM, et al. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles. Adv Healthcare Mater. 2021\/8\/11;11(5). https:\/\/doi.org\/10.1002\/adhm.202101202.","DOI":"10.1002\/adhm.202101202"},{"issue":"35","key":"8074_CR139","doi-asserted-by":"publisher","first-page":"16652","DOI":"10.1039\/d4nr02191f","volume":"16","author":"S Sulthana","year":"2024","unstructured":"Sulthana S, Shrestha D, Aryal S. Maximizing liposome tumor delivery by hybridizing with tumor-derived extracellular vesicles. Nanoscale. 2024;16(35):16652\u201363. https:\/\/doi.org\/10.1039\/d4nr02191f.","journal-title":"Nanoscale"},{"key":"8074_CR140","doi-asserted-by":"publisher","unstructured":"Mizenko RR, Arun V, Meshkanian D, et al. Single-particle characterization reveals heterogeneous extracellular vesicle fusion with liposomes. Small Methods. 2026\/2\/6;e01195. https:\/\/doi.org\/10.1002\/smtd.202501195.","DOI":"10.1002\/smtd.202501195"},{"key":"8074_CR141","doi-asserted-by":"publisher","first-page":"102847","DOI":"10.1016\/j.mtbio.2026.102847","volume":"37","author":"Y Wu","year":"2026","unstructured":"Wu Y, Wang C, Fang K, et al. Bionic design based on liposome-exosome hybrid nanoparticles for synergistic delivery of paeonol to achieve neuroprotection and improvement of motor function in Parkinson\u2019s disease model mice. Mater Today Bio. 2026\/1\/23;37:102847. https:\/\/doi.org\/10.1016\/j.mtbio.2026.102847.","journal-title":"Mater Today Bio"},{"issue":"2","key":"8074_CR142","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1039\/d5ra04927j","volume":"16","author":"S Sonar","year":"2026","unstructured":"Sonar S, Das A, Nyahatkar S, et al. Hybrid exosomes: a rising horizon for precision cancer therapy. RSC Adv. 2026\/1\/2;16(2):1292\u2013309. https:\/\/doi.org\/10.1039\/d5ra04927j.","journal-title":"RSC Adv"},{"key":"8074_CR143","doi-asserted-by":"publisher","unstructured":"Baena JC, Cabrera-Salcedo SC, Carrera Su\u00e1rez Y, et al. The avatar principle: exosomal dynamics guiding tumor adaptation and next-generation therapeutic strategies. J Nanobiotechnol. 2026\/2\/11;24(1). https:\/\/doi.org\/10.1186\/s12951-026-04089-8.","DOI":"10.1186\/s12951-026-04089-8"},{"issue":"3","key":"8074_CR144","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/cancers18030537","volume":"18","author":"FA Alhumaydhi","year":"2026","unstructured":"Alhumaydhi FA, Anwar S. Extracellular vesicles in cancer: mechanistic insights and clinical applications. Cancers. 2026\/2\/6;18(3):537. https:\/\/doi.org\/10.3390\/cancers18030537.","journal-title":"Cancers"},{"key":"8074_CR145","doi-asserted-by":"publisher","unstructured":"Shimamoto N, Sumiyama K, Fujita Y. Extracellular vesicle biomarkers in pancreatic ductal adenocarcinoma: from bulk detection to single-extracellular vesicle profiling and endoscopic liquid biopsy. J Gastroenterol. 2026\/2\/6. https:\/\/doi.org\/10.1007\/s00535-026-02350-3.","DOI":"10.1007\/s00535-026-02350-3"},{"key":"8074_CR146","doi-asserted-by":"publisher","first-page":"103365","DOI":"10.1016\/j.ebiom.2021.103365","volume":"67","author":"E Zhou","year":"2021","unstructured":"Zhou E, Li Y, Wu F, et al. Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy. EBioMedicine. 2021\/5;67:103365. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103365.","journal-title":"EBioMedicine"},{"issue":"8","key":"8074_CR147","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.3390\/cancers14081984","volume":"14","author":"E Ampudia-Mesias","year":"2022","unstructured":"Ampudia-Mesias E, El-Hadad S, Cameron CS, et al. SRPX emerges as a potential tumor Marker in the extracellular vesicles of glioblastoma. Cancers. 2022\/4\/14;14(8):1984. https:\/\/doi.org\/10.3390\/cancers14081984.","journal-title":"Cancers"},{"key":"8074_CR148","doi-asserted-by":"publisher","unstructured":"GKdS L, Dexheimer GM, Biolchi V, Seewald RA, Chies JAB. Prostate tumor markers: diagnosis, prognosis and management. Genet Mol Biol. 2024\/2\/26;46(3 Suppl 1):e20230136. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2023-0136.","DOI":"10.1590\/1678-4685-GMB-2023-0136"},{"key":"8074_CR149","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ymeth.2020.02.003","volume":"177","author":"A Yekula","year":"2020","unstructured":"Yekula A, Muralidharan K, Kang KM, Wang L, Balaj L, Carter BS. From laboratory to clinic: translation of extracellular vesicle based cancer biomarkers. Methods. 2020\/5\/1;177:58\u201366. https:\/\/doi.org\/10.1016\/j.ymeth.2020.02.003.","journal-title":"Methods"},{"issue":"Pt2","key":"8074_CR150","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.semcancer.2022.06.001","volume":"86","author":"SE Wang","year":"2022","unstructured":"Wang SE. Extracellular vesicles in cancer therapy. Semin Cancer Biol. 2022\/11;86(Pt2):296\u2013309. https:\/\/doi.org\/10.1016\/j.semcancer.2022.06.001.","journal-title":"Semin Cancer Biol"},{"key":"8074_CR151","doi-asserted-by":"publisher","unstructured":"Genova C, Marconi S, Chiorino G, et al. Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab. Clin Exp Med. 2024\/8\/6;24(1). https:\/\/doi.org\/10.1007\/s10238-024-01427-8.","DOI":"10.1007\/s10238-024-01427-8"},{"issue":"2","key":"8074_CR152","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3724\/abbs.2025123","volume":"58","author":"Y Teng","year":"2025","unstructured":"Teng Y, Huang G, Yang H. Unveiling the multifaceted roles of extracellular vesicles in cancer: insights from molecular imaging and engineering strategies. Acta Biochim. Biophys. Sin. (Shanghai). 2025\/8\/8;58(2):216\u201330. https:\/\/doi.org\/10.3724\/abbs.2025123.","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"19","key":"8074_CR153","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.3390\/ijms20194799","volume":"20","author":"Z Nowicka","year":"2019","unstructured":"Nowicka Z, Stawiski K, Tomasik B, Fendler W. Extracellular miRnas as biomarkers of Head and neck cancer progression and metastasis. Int J Mol Sci. 2019\/9\/27;20(19):4799. https:\/\/doi.org\/10.3390\/ijms20194799.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"8074_CR154","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.3390\/cancers14102435","volume":"14","author":"F Pantano","year":"2022","unstructured":"Pantano F, Zalfa F, Iuliani M, et al. Large-scale profiling of extracellular vesicles identified miR-625-5p as a novel biomarker of immunotherapy response in advanced non-small-cell Lung cancer patients. Cancers. 2022\/5\/14;14(10):2435. https:\/\/doi.org\/10.3390\/cancers14102435.","journal-title":"Cancers"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08074-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:28:53Z","timestamp":1781645333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08074-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8074"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08074-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"553"}}